TABLE 3.
Survival, living status and failure pattern
| IC+RT arm | CCRT arm | p‐value | |
|---|---|---|---|
| Survival rate, % | |||
| 3‐year PFS rate | 72.2 | 82.6 | 0.279 |
| 3‐year OS rate | 87.8 | 92.8 | 0.911 |
| 3‐year LRRFS rate | 92.3 | 94.7 | 0.652 |
| 3‐year DMFS rate | 82.7 | 88.2 | 0.586 |
| Living status, n (%) | 0.295 | ||
| Living | 74 (74.7) | 77 (77.8) | |
| Death | 17 (17.2) | 19 (19.2) | |
| Lost | 8 (8.1) | 3 (3) | |
| Failure pattern, n (%) | 22 (22.2) | 18 (18.2) | 0.479 |
| Locoregional | 9 (9.1) | 7 (7.1) | 0.602 |
| Distant | 16 (16.2) | 14 (14.1) | 0.692 |
| Locoregional and distant | 3 (3) | 3 (3) | 1 |
Abbreviations: CCRT, concurrent chemoradiotherapy; DMFS, distant metastasis‐free survival; IC, induction chemotherapy; LRRFS, locoregional recurrence–free survival; OS, overall survival; PFS, progression‐free survival; RT, radiotherapy.